Clinical-Supply Manufacturing
Product Description
BIOLOGICAL E. LTD
-
Country/Region:India
-
On CPHI since:2015
-
Employees:5000+
Company types
Categories
Specifications
BIOLOGICAL E. LTD
-
Country/Region:India
-
On CPHI since:2015
-
Employees:5000+
Company types
More Products from BIOLOGICAL E. LTD (21)
-
Product HepB (hepatitis B vaccine (rDNA))
Biological E limited supplies wide range of biological products which includes HepB (hepatitis B vaccine (rDNA). It belongs to domestic vaccines category. It immunization polio. Packaging: 0.5 ml vial, 5 ml vial 1ml vial. contact us for more information. -
Product Analytical method development, qualification and validation
BE BioSol provides phase-appropriate analytical support for biologics, vaccines and injectable drug products. Our capabilities include developing and optimizing methods for identity, purity, potency, concentration, product-related variants, impurities and microbiological quality. We also support stability-... -
Product Aseptic Liquid-Vial Filling
BE BioSol provides aseptic liquid-vial filling services for biologics, vaccines and complex injectable products—from clinical programs through large-scale commercial supply. Our integrated teams support formulation, process development, technology transfer, scale-up and validation, providing clients with a... -
Product Cartridge Filling
BE BioSol provides aseptic cartridge-filling services for biologics and complex injectable products intended for use in reusable pens, autoinjectors and other patient-friendly delivery systems. Our integrated teams support programs from formulation and process development through technology transfer, valid... -
Product Cell-line, upstream and downstream process development
BE BioSol provides integrated process-development support for biologics, vaccines and recombinant proteins. Our capabilities include cell-line and clone selection, media and feed optimization, fermentation and cell-culture process development, and scale-up. Downstream services include harvest clarification... -
Product Clinical and Commercial Sterile Manufacturing
BE BioSol provides flexible sterile-manufacturing solutions that support injectable products from early clinical development through launch and sustained commercial supply. Our capabilities span liquid and lyophilized vials, prefilled syringes and cartridges, enabling clients to select the presentation and... -
Product Commercial Technology Transfer and Lifecycle Management
BE BioSol supports the efficient transfer of established commercial products into our manufacturing facilities while protecting product quality, regulatory compliance and continuity of supply. Our cross-functional teams develop structured transfer plans based on a detailed assessment of the existing proces... -
Product Formulation and drug-product development
BE BioSol provides formulation and drug-product development services designed to improve product stability, manufacturability and delivery. Capabilities include buffer and excipient screening, pH and concentration optimization, stability and stress studies, container-closure compatibility, and lyophilizati... -
Product Integrated biologics and vaccine development
E BioSol provides integrated development support for biologics and vaccines, helping clients advance programs from early development through clinical supply, technology transfer and commercial manufacturing.
Our services include:
• Developability and technical feasibility assessments... -
Product Integrated Development-to-Commercial Supply
BE BioSol provides an integrated pathway that supports biologics, vaccines and sterile injectable products from early development through clinical manufacturing and dependable commercial supply. By bringing scientific, technical, regulatory and manufacturing expertise together within one organization, we h... -
Product Lyophilized-Vial Filling and Cycle Development
BE BioSol provides integrated formulation, lyophilization-cycle development and aseptic vial-filling services for biologics, vaccines and complex injectable products requiring enhanced stability or extended shelf life. Our teams support programs from early development and clinical manufacturing through pro... -
Product Mammalian Drug-Substance Manufacturing with four 5,000 L Single-Use Bioreactor Trains
BE BioSol is expanding its mammalian drug-substance manufacturing capabilities with four 5,000 L single-use bioreactor trains, providing up to 20,000 L of total production capacity. The flexible, modular design will support efficient product changeover, parallel manufacturing campaigns and scalable product...